CytoSorbents Corp. (CTSO)
6.01
+0.66
(+12.34%)
USD |
NASDAQ |
Oct 22, 16:00
5.71
-0.30
(-4.99%)
After-Hours: 05:38
CytoSorbents Net Income (Quarterly) : -4.417M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.417M |
| March 31, 2026 | -5.129M |
| December 31, 2025 | -5.497M |
| September 30, 2025 | -3.17M |
| June 30, 2025 | 1.947M |
| March 31, 2025 | -1.478M |
| December 31, 2024 | -7.884M |
| September 30, 2024 | -2.768M |
| June 30, 2024 | -4.294M |
| March 31, 2024 | -6.089M |
| December 31, 2023 | -6.135M |
| September 30, 2023 | -9.194M |
| June 30, 2023 | -6.153M |
| March 31, 2023 | -7.326M |
| December 31, 2022 | -0.7661M |
| September 30, 2022 | -12.20M |
| June 30, 2022 | -10.88M |
| March 31, 2022 | -8.966M |
| December 31, 2021 | -9.307M |
| September 30, 2021 | -6.406M |
| June 30, 2021 | -4.678M |
| March 31, 2021 | -4.168M |
| December 31, 2020 | -0.6777M |
| September 30, 2020 | -0.8397M |
| June 30, 2020 | -2.867M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.453M |
| December 31, 2019 | -3.949M |
| September 30, 2019 | -6.885M |
| June 30, 2019 | -3.547M |
| March 31, 2019 | -4.884M |
| December 31, 2018 | -5.403M |
| September 30, 2018 | -3.005M |
| June 30, 2018 | -5.821M |
| March 31, 2018 | -2.982M |
| December 31, 2017 | -3.147M |
| September 30, 2017 | -2.054M |
| June 30, 2017 | -1.735M |
| March 31, 2017 | -1.525M |
| December 31, 2016 | -4.906M |
| September 30, 2016 | -2.188M |
| June 30, 2016 | -3.005M |
| March 31, 2016 | -1.836M |
| December 31, 2015 | -2.002M |
| September 30, 2015 | -2.847M |
| June 30, 2015 | 1.434M |
| March 31, 2015 | -4.717M |
| December 31, 2014 | -4.995M |
| September 30, 2014 | -1.498M |
| June 30, 2014 | -1.854M |
| March 31, 2014 | -0.9751M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 9.633M |
| Total Expenses (Quarterly) | 14.05M |
| EPS Diluted (Quarterly) | -1.407 |
| Enterprise Value | 44.46M |
| Gross Profit Margin (Quarterly) | 73.18% |
| Profit Margin (Quarterly) | -45.85% |
| Earnings Yield | -96.55% |
| Normalized Earnings Yield | -90.14 |